European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street mixed as oil prices surge, investors await earnings, economic data
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.45 +0.17 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.28 | 52 Week High | $37.39 | |||
| Open | $28.42 | 52 Week Low | $28.25 | |||
| Day High | $28.50 | P/E | 17.24 | |||
| Day Low | $28.28 | EPS | $1.65 | |||
| Volume | 10,290,675 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.45 +0.17 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.28 | 52 Week High | $37.39 | |||
| Open | $28.42 | 52 Week Low | $28.25 | |||
| Day High | $28.50 | P/E | 17.24 | |||
| Day Low | $28.28 | EPS | $1.65 | |||
| Volume | 10,290,675 | |||||
